[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 27, 1994

Silicone Gel Breast Implants-Reply

Author Affiliations

Food and Drug Administration Rockville, Md

JAMA. 1994;272(4):273-274. doi:10.1001/jama.1994.03520040031028

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In Reply.  —We agree with Dr Agnew that uncertainties about the safety of silicone gel breast implants make it impossible to provide women with adequate information about their risks. However, some risks have been established (eg, capsular contracture and ruptures do occur). This incidence of ruptures and their relationship to serious problems, such as autoimmune disease, are under intense investigation. Dr Kent and Dr Brody cite studies that they say show no relationship between silicone gel leaks and autoimmune disorders. At least some of those studies have been criticized for lacking sufficient power to definitively determine whether there is an increased incidence of autoimmune disease among women with implants. But rather than debate the merits of particular studies here, the critical point is that significant questions remain about risks associated with these devices. Under these circumstances, the FDA is not prepared to authorize their widespread use.We agree with Dr

First Page Preview View Large
First page PDF preview
First page PDF preview